超声引导下高渗葡萄糖注射对于距腓前韧带慢性损伤的疗效研究  

Efficacy of ultrasound-guided hypertonic glucose injection against chronic injury of anterior talofibular ligament

作　　者：廖东初 毛佶 胡泽莹 王明峰 吴志彬 李鹭 朱俊杰 吴洪光 王玉琪 毛龙飞 孙熙洋 王雅珍 LIAO Dongchu;MAO Ji;HU Zeying;WANG Mingfeng;WU Zhibin;LI Lu;ZHU Junjie;WU Hongguang;WANG Yuqi;MAO Longfei;SUN Xiyang;WANG Yazhen(Department of Rehabilitation,Xiamen Army Special Service Convalescence Center,Xiamen 361002;Department of Ultrasound Diagnosis,General Hospital of Southern Theater Command,Guangzhou 510000,China)

机构地区：[1]陆军厦门特勤疗养中心康复科,厦门361002 [2]南部战区总医院超声诊断科,广州510000

出　　处：《空军航空医学》2024年第4期331-334,共4页AVIATION MEDICINE OF AIR FORCE

摘　　要：目的 研究超声引导下高渗葡萄糖注射对于距腓前韧带慢性损伤患者的治疗效果,为临床保守治疗距腓前韧带慢性损伤提供相关经验。方法选取单侧踝关节扭伤慢性疼痛患者60例,将患者随机分为A组、B组,A组注射高渗葡萄糖治疗,B组行超短波联合肌内效贴布治疗,分别评估患者治疗前与治疗后1、3个月和6个月的距腓前韧带超声表现、视觉模拟评分(Visual Analogue Scale,VAS)和美国足踝外科医师协会(American Orthopedic Foot and Ankle Society,AOFAS)后足评分。结果 2组治疗期间VAS评分结果显示,时间效应、组间效应和交互作用差异均有统计学意义(F组别=34.276,F时间=369.061,F交互=23.759,P均<0.001)。2组治疗期间AOFAS评分结果显示,时间效应、组间效应和交互作用差异均有统计学意义(F组别=97.236,F时间=322.951,F交互=11.175,P均<0.001)。A组治疗后1、3个月和6个月的VAS评分均较前改善,差异具有统计学意义(P均<0.001);A组治疗后1、3个月和6个月的AOFAS评分均较前改善,差异具有统计学意义(P均<0.001);B组治疗后1、3个月和6个月的VAS评分均较前改善,差异具有统计学意义(P均<0.001);B组治疗后1、3个月和6个月的AOFAS评分均较前改善,差异具有统计学意义(P均<0.001);治疗后1个月、3个月、6个月,A组VAS分数均比B组低,且差异有统计学意义(P=0.010、<0.001、<0.001);治疗后1、3个月和6个月,A组AOFAS分数均比B组高,且差异有统计学意义(P均<0.001)。结论 对于距腓前韧带慢性损伤患者,超声引导下行高渗葡萄糖注射治疗安全、有效,值得临床进一步推广。Objective To observe the therapeutic effect of ultrasound-guided hypertonic glucose injection against chronic anterior talofibular ligament injury so as to provide tips for clinical conservative treatment.Methods Sixty patients with chronic pain caused by unilateral ankle sprain were randomly divided into group A and group B.Patients in group A were treated with hypertonic glucose injection while patients in group B underwent ultrashort wave combined with kinesio taping.The ultrasound manifestations of the anterior talofibular ligament and visual analogue scale(VAS)scores were evaluated before treatment and 1 month,3 and 6 months after treatment.Results VAS scores and AOFAS scores showed that there were statistically significant differences in time effect,inter-group effect and interactions(Fgroup=34.276,97.236,Fume=369.061,322.951,Fimteraction=23.759,11.175,all P<0.001).The VAS scores of group A at 1,3 and 6 months after treatment were all improved,and the differences were statistically significant(all P<0.o01),The AOFAS scores of group A at 1,3 and 6 months after treatment were all improved,and the differences were statistically significant(all P<0.001),The case was the same with VAS scores(all P<0.001)and AOFAS scores(all P<0.001)of group B.At 1,3 and 6 months after treatment,the VAS scores of group A were lower than those of group B,and the difference was statistically significant(P=0.010,<0.001,<0.001),while the AOFAS scores of group A were higher,and the difference was statistically significant(all P<0.oo1).Conclusion For patients with chronic anterior talofibular ligament injury,ultrasound-guided hypertonic glucose injection is safe and effective,which should be made more accessible.

关 键 词：高渗葡萄糖 距腓前韧带 增生疗法 超短波 肌内效贴 

分 类 号：R684[医药卫生—骨科学] R445-1[医药卫生—外科学]